Nearly Half of Cancer Patients Taking Ivermectin & Mebendazole Reported Tumor Disappearance or Reduction After 6 Months
2026 real-world study: 84.4% of cancer patients taking ivermectin and mebendazole reported clinical benefit at 6 months, with nearly half seeing tumor reduction.





